Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > OK Providers > Oncologists

Dr. Mohammad Razaq, MD

(Mohammad Abdul Razaq, MD)

(No ratings)

Specializes in: Oncology (Cancer Care) and Hematology (Blood Disorders)

4401 Mcauley Boulevard Suite 2700
Oklahoma City, OK 73120

(405) 751-4343

Dr. Mohammad Razaq, MD is an oncologist in Oklahoma City, OK specializing in oncology (cancer care) and hematology (blood disorders). Dr. Mohammad Razaq, MD is affiliated with Mercy Health System, Mercy Clinic Oncology and Hematology - Oklahoma City South and MERCY CLINIC OKLAHOMA COMMUNITIES.

Office Locations

Address:

5200 E. Interstate 240 Service Road Suite 330 Mercy Clinic Oncology and Hematology
Oklahoma City, OK 73135

Address:

4401 Mcauley Boulevard Suite 2700
Oklahoma City, OK 73120

biological response modifier (BRM) therapy	94
chemotherapy	94
doctor visit	370
hospital care	209
inpatient care	209
minimally invasive procedures	93
port flush	25

**Gender**
Male	145
Female	176

**Ethnicity**
Non-Hispanic White	244
Black	40
Hispanic	0
Asian	0
Other	0
Native American	18

**Age**
From 65 to 74	162
From 75 to 84	69
85 and over	14
Less than 65	76

Hypertension	67
High Cholesterol	41
Stroke	4
Ischemic Heart Disease	35
Depression	27
Chronic Kidney Disease	30
Asthma	9
Osteoperosis	6
Atrial Fibrilation	6
Heart Failure	19
Chronic Obstructive Pulmonary Disease	27
Diabetes	33
Dementia	7
Cancer	38

biological response modifier (BRM) therapy	64
chemotherapy	64
doctor visit	523
hospital care	270
inpatient care	270
minimally invasive procedures	63
port flush	29

**Gender**
Male	167
Female	173

**Ethnicity**
Non-Hispanic White	266
Black	33
Hispanic	0
Asian	0
Other	0
Native American	26

**Age**
From 65 to 74	163
From 75 to 84	84
85 and over	14
Less than 65	79

Hypertension	67
High Cholesterol	42
Stroke	6
Ischemic Heart Disease	36
Depression	27
Chronic Kidney Disease	35
Asthma	6
Osteoperosis	6
Atrial Fibrilation	6
Heart Failure	23
Chronic Obstructive Pulmonary Disease	29
Diabetes	29
Dementia	5
Cancer	41

biological response modifier (BRM) therapy	151
chemotherapy	151
doctor visit	540
hospital care	229
inpatient care	229
minimally invasive procedures	167
port flush	48
preventive care	11
vaccines	11

**Gender**
Male	366
Female	426

**Ethnicity**
Non-Hispanic White	608
Black	88
Hispanic	0
Asian	0
Other	0
Native American	50

**Age**
From 65 to 74	402
From 75 to 84	168
85 and over	22
Less than 65	200

Hypertension	66
High Cholesterol	40
Stroke	5
Ischemic Heart Disease	36
Depression	30
Chronic Kidney Disease	37
Asthma	18
Osteoperosis	5
Atrial Fibrilation	9
Heart Failure	22
Chronic Obstructive Pulmonary Disease	27
Diabetes	31
Dementia	4
Cancer	39

biological response modifier (BRM) therapy	139
chemotherapy	139
doctor visit	725
hospital care	75
inpatient care	75
minimally invasive procedures	159
port flush	35

**Gender**
Male	216
Female	261

**Ethnicity**
Non-Hispanic White	377
Black	50
Hispanic	0
Asian	0
Other	0
Native American	25

**Age**
From 65 to 74	253
From 75 to 84	103
85 and over	23
Less than 65	98

Hypertension	66
High Cholesterol	39
Stroke	4
Ischemic Heart Disease	35
Depression	25
Chronic Kidney Disease	37
Asthma	27
Osteoperosis	6
Atrial Fibrilation	8
Heart Failure	22
Chronic Obstructive Pulmonary Disease	26
Diabetes	32
Dementia	8
Cancer	42

biological response modifier (BRM) therapy	222
chemotherapy	222
doctor visit	679
hospital care	89
inpatient care	89
minimally invasive procedures	238
port flush	36

**Gender**
Male	244
Female	286

**Ethnicity**
Non-Hispanic White	435
Black	50
Hispanic	0
Asian	0
Other	0
Native American	26

**Age**
From 65 to 74	277
From 75 to 84	126
85 and over	25
Less than 65	102

Hypertension	70
High Cholesterol	40
Stroke	4
Ischemic Heart Disease	35
Depression	28
Chronic Kidney Disease	44
Asthma	9
Osteoperosis	8
Atrial Fibrilation	9
Heart Failure	20
Chronic Obstructive Pulmonary Disease	24
Diabetes	34
Dementia	7
Cancer	41

biological response modifier (BRM) therapy	142
chemotherapy	142
doctor visit	818
hospital care	49
inpatient care	49
minimally invasive procedures	141
port flush	16

**Gender**
Male	191
Female	157

**Ethnicity**
Non-Hispanic White	295
Black	22
Hispanic	0
Asian	0
Other	0
Native American	17

**Age**
From 65 to 74	192
From 75 to 84	86
85 and over	15
Less than 65	55

Hypertension	70
High Cholesterol	46
Stroke	5
Ischemic Heart Disease	37
Depression	29
Chronic Kidney Disease	37
Asthma	7
Osteoperosis	5
Atrial Fibrilation	10
Heart Failure	22
Chronic Obstructive Pulmonary Disease	30
Diabetes	25
Dementia	7
Cancer	41

doctor visit	812
hospital care	39
inpatient care	39
preventive care	16
vaccines	16

**Gender**
Male	170
Female	83

**Ethnicity**
Non-Hispanic White	216
Black	0
Hispanic	0
Asian	0
Other	0
Native American	18

**Age**
From 65 to 74	121
From 75 to 84	76
85 and over	17
Less than 65	39

Hypertension	75
High Cholesterol	48
Stroke	7
Ischemic Heart Disease	40
Depression	29
Chronic Kidney Disease	42
Asthma	6
Osteoperosis	7
Atrial Fibrilation	12
Heart Failure	22
Chronic Obstructive Pulmonary Disease	33
Diabetes	30
Dementia	11
Cancer	48

doctor visit	436
hospital care	249
inpatient care	249

**Gender**
Male	141
Female	115

**Ethnicity**
Non-Hispanic White	218
Black	16
Hispanic	0
Asian	0
Other	0
Native American	11

**Age**
From 65 to 74	115
From 75 to 84	79
85 and over	33
Less than 65	29

Hypertension	75
High Cholesterol	65
Stroke	7
Ischemic Heart Disease	57
Depression	32
Chronic Kidney Disease	51
Asthma	8
Osteoperosis	7
Atrial Fibrilation	20
Heart Failure	38
Chronic Obstructive Pulmonary Disease	32
Diabetes	38
Dementia	13
Cancer	39

doctor visit	2218
hospital care	784
inpatient care	784

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Mohammad Razaq, MD for Medicare patients.

The highest averages for the top procedures that Dr. Mohammad Razaq, MD treated as an oncologist in Oklahoma City, OK were hospital care, inpatient care, minimally invasive procedures and chemotherapy.

biological response modifier (BRM) therapy	135
chemotherapy	135
doctor visit	794
hospital care	221
inpatient care	221
minimally invasive procedures	144
preventive care	14
vaccines	14

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Mohammad Razaq, MD.

**Gender**
Male	164
Female	167

**Ethnicity**
Black / African American	29
Asian / Pacific Islander	0
Non-Hispanic White	265
Native American / Alaskan Native	19
Hispanic	0
Other	0

**Age**
75 to 84	79
85 and over	16
Less than 65	67
65 to 74	168

Average of Total of Conditions of Medicare patients treated by Dr. Mohammad Razaq, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Mohammad Razaq, MD treated were hypertension, high cholesterol, cancer and chronic kidney disease.

Hypertension	55
High Cholesterol	36
Stroke	4
Ischemic Heart Disease	31
Depression	22
Chronic Kidney Disease	31
Asthma	9
Osteoporosis	5
Heart Failure	18
Chronic Obstructive Pulmonary Disease	22
Diabetes	25
Atrial Fibrillation	8
Cancer	32
Dementia	6

Education & Training

He has a state license in Illinois.

Licensed In: Illinois

Affiliations & Hospitals

Dr. Mohammad Razaq, MD is associated with these hospitals and organizations:

Mercy Health System

Mercy Clinic Oncology and Hematology - Oklahoma City South

MERCY CLINIC OKLAHOMA COMMUNITIES

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Mohammad Razaq, MD appears to accept the following insurance providers: HealthChoice, HealthSmart, USA Managed Care Organization, United Healthcare, Aetna, TRICARE (Humana Military), Three Rivers, Humana, Coventry, Cigna, Anthem BlueCross BlueShield, MultiPlan/PHCS, Preferred Community Choice, Tribute, GlobalHealth, Healthcare Highways, Oklahoma Health Network, Oklahoma State Medical Association (OSMA), National Preferred Provider Network, Indian Health Services, Community Care of OK and Chickasaw Nation.

Insurance Accepted by Provider includes:

According to our sources, Dr. Mohammad Razaq, MD accepts the following insurance providers:

HealthChoice

HealthSmart

USA Managed Care Organization

United Healthcare

Aetna

TRICARE (Humana Military)

Three Rivers

Humana

Coventry

Cigna

Anthem BlueCross BlueShield

MultiPlan/PHCS

Preferred Community Choice

Tribute

GlobalHealth

Healthcare Highways

Oklahoma Health Network

Oklahoma State Medical Association (OSMA)

National Preferred Provider Network

Indian Health Services

Community Care of OK

Chickasaw Nation

Show More

Ratings & Reviews

Dr. Mohammad Razaq, MD does not have any reviews yet, be the first to leave a review of Dr. Mohammad Razaq, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Mohammad Razaq, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Merck Sharp & Dohme Corporation	$138,174 KEYTRUDA $133,953	$4,221
AstraZeneca Pharmaceuticals LP	$8,546 TAGRISSO $4,737	LYNPARZA $1,823	IMFINZI $1,698	Enhertu $71	CALQUENCE $29	Other $188
Celgene Corporation	$5,016 Abraxane $2,469	Reblozyl $61	Pomalyst $37	OPDUALAG $30	$2,419
E.R. Squibb & Sons, L.L.C.	$4,050 OPDIVO $2,802	Inrebic $36	Reblozyl $12	$1,200
Incyte Corporation	$3,826 JAKAFI $22	PEMAZYRE $19	$3,785
Other	$7,701 KEYTRUDA $3,482	clonoSEQ $1,200	EMEND $200	IBRANCE $190	Copiktra $170	Other $2,459

**Types of Payments**
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$122,488
Travel and Lodging	$21,262
Consulting Fee	$17,167
Food and Beverage	$6,073
Education	$324

Research Payments

Dr. Mohammad Razaq, MD has received 79 research payments totaling $837,942.

Biography

Dr. Mohammad Razaq is a physician who specializes in oncology (cancer care) and hematology (blood disorders). He is professionally affiliated with Mercy. He is not accepting new patients at this time according to Yext.